跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLAMIN SOLUTION FOR INFUSION - HSA Drug Approval Details
Approvals
/
HSA
/
GLAMIN SOLUTION FOR INFUSION
Approved
THERAPEUTIC
GLAMIN SOLUTION FOR INFUSION
FRESENIUS KABI AUSTRIA GMBH
🇸🇬 Health Sciences Authority
Approval Date
Jul 27, 1998
Approval ID
a6e267c25c6ef5c4
Company
FRESENIUS KABI AUSTRIA GMBH
Type
Therapeutic
Approval Details
Approval Id
a6e267c25c6ef5c4
Drug Name
GLAMIN SOLUTION FOR INFUSION
Product Name
GLAMIN SOLUTION FOR INFUSION
Approval Number
SIN09906P
Approval Date
1998-07-27
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
B05BA01
Atc Item Name
amino acids
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
TRYPTOPHAN
1.9 g/1000 ml
LEUCINE
7.9 g/1000 ml
SERINE
4.5 g/1000 ml
LYSINE ACETATE
12.7 g/1000 ml
GLYCYL-TYROSINE DIHYDRATE
3.45 g/1000 ml
METHIONINE
5.6 g/1000 ml
VALINE
7.3 g/1000 ml
ISOLEUCINE
5.6 g/1000 ml
GLUTAMIC ACID
5.6 g/1000 ml
ARGININE
11.3 g/ 1000 ml
PHENYLALANINE
5.85 g/1000 ml
PROLINE
6.8 g/1000 ml
THREONINE
5.6 g/1000 ml
GLYCYL-GLUTAMINE HYDRATE
30.27 g/1000 ml
ALANINE
16 g/1000 ml
ASPARTIC ACID
3.4 g/1000 ml
HISTIDINE
6.8 g/1000 ml
ALANINE
16 G/1,000 ML
ARGININE
11.3 G/ 1,000 ML
ASPARTIC ACID
3.4 G/1,000 ML
GLUTAMIC ACID
5.6 G/1,000 ML
GLYCYL-GLUTAMINE HYDRATE
30.27 G/1,000 ML
GLYCYL-TYROSINE DIHYDRATE
3.45 G/1,000 ML
HISTIDINE
6.8 G/1,000 ML
ISOLEUCINE
5.6 G/1,000 ML
LEUCINE
7.9 G/1,000 ML
LYSINE ACETATE
12.7 G/1,000 ML
METHIONINE
5.6 G/1,000 ML
PHENYLALANINE
5.85 G/1,000 ML
PROLINE
6.8 G/1,000 ML
SERINE
4.5 G/1,000 ML
THREONINE
5.6 G/1,000 ML
TRYPTOPHAN
1.9 G/1,000 ML
VALINE
7.3 G/1,000 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 27, 1998
Approval ID
a6e267c25c6ef5c4
Type
Therapeutic
Back to HSA Approvals